trending Market Intelligence /marketintelligence/en/news-insights/trending/wsmtvzomxv5n0jgh3udmtw2 content esgSubNav
In This List

Centene invests in pharmacy benefit manager RxAdvance

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

The Big Picture 2022 Insurance Industry Outlook


Centene invests in pharmacy benefit manager RxAdvance

Centene Corp. has made an initial, strategic investment in RxAdvance Corp., a full-service pharmacy benefit manager.

As part of the initial transaction, Centene has certain rights to expand its equity investment in the future.

RxAdvance founder and CEO Ravi Ika will continue in his current role as CEO of the company and John Sculley will remain chairman and chief marketing officer. Jesse Hunter, Centene's executive vice president of mergers and acquisitions and chief strategy officer, joined RxAdvance's board, effective March 13.